Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,340.00
Bid: 12,360.00
Ask: 12,362.00
Change: -76.00 (-0.61%)
Spread: 2.00 (0.016%)
Open: 12,234.00
High: 12,370.00
Low: 12,164.00
Prev. Close: 12,416.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Opening snapshot: Stocks sell off continues...

Mon, 15th Jun 2020 08:52

Welcome to the home for real-time coverage of European equity markets brought to you by Reuters
stocks reporters. You can share your thoughts Joice Alves (joice.alves@thomsonreuters.com) and
Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo
(stefano.rebaudo@thomsonreuters.com) in Milan.

OPENING SNAPSHOT: STOCKS SELL OFF CONTINUES... (0745 GMT)

European shares slide on fears of second wave of coronavirus cases with Beijing reporting
new infections.

The pan-European index fell 2.5% with basic resources and travel
leading the losses down almost 4%.

In terms of single stocks, BP is down 5% after it said it will incur an up to $17.5 billion
writedown in the value of its assets.

But on a positive note, Bunzl jumped 8.5% as it forecast an increase in revenue for the
first half of the year, while shares at biopharmaceutical company Ucb jumped 10%.

(Joice Alves)

*****

ON THE RADAR: SENSIRION, EASYJET, ASTRAZENECA and M&A (0645 GMT)

The disconnect between market sentiment and corporate news flow continues with futures
pointing to a start of the week in the red for European bourses as investors fear a second wave
of infections. Meantime, some companies prepare to return to work or engage in M&A deals.

EasyJet resumes flying for the first time since March 30 with COVID-19 measures in place and
Volkswagen will begin sending workers back to plant in Mexico on Tuesday.

Swiss sensor maker Sensirion lifts 2020 outlook as sales skyrocketed on COVID-19 demand
spike for ventilator sensors, while H&M's March-May sales tumble 50%, slightly less than
expected.

AstraZeneca signed a contract with European governments to supply the region with its
potential vaccine against the coronavirus.

In the M&A world, Cineworld scraps deal to buy Cineplex; while Metro Bank is in exclusive
talks to buy peer-to-peer lender RateSetter and Italy's BPER Banca approved a revised deal with
Intesa Sanpaolo to address antitrust issues in Intesa's takeover bid for UBI Banca.

Germany says coronavirus tracing smartphone app ready to go. Deutsche Telekom and software
company SAP are involved in the project.

BP will incur an up to $17.5 billion writedown in the value of its assets after lowering its
long-term oil and gas price outlook in expectation of an accelerated transition away from fossil
fuels. The company said that the coronavirus pandemic will accelerate the pace of transition to
a lower-carbon economy.

(Joice Alves)

*****

MORNING CALL: FEARS OF SECOND WAVES (0545 GMT)

Futures are pointing to a start of the week in the red for European bourses as risk appetite
gets a hit by fears of a second wave of COVID-19 infections after Beijing recorded new
infections in recent days.

Dozens of new cases all linked to a major wholesale food market were enough to encourage
investors to seek for safe-heavens across the world as authorities in China locked down housing
districts near the market.

News flow in Europe could help to improve the mood as countries are easing border controls
and the UK opens its shops.

Global coronavirus cases have crossed 7.86 million with 430,501? deaths, according to a
Reuters tally.

(Joice Alves)

*****

More News
24 Oct 2023 11:06

AstraZeneca says US accepts self-administered flu vaccine for review

(Alliance News) - AstraZeneca PLC on Tuesday said the US health watchdog has approved a review for its FluMist Quadrivalent self-administered flu vaccine, for which the drugmaker is seeking a green light.

Read more
23 Oct 2023 17:50

AstraZeneca celebrates drug trial results for cancer indications

(Alliance News) - AstraZeneca PLC on Monday said new drugs, developed in partnership with Daiichi Sankyo Co Ltd, showed positive results in patients with solid tumours, lung and breast cancer.

Read more
23 Oct 2023 17:08

LONDON MARKET CLOSE: Stocks largely down on Middle East hostilities

(Alliance News) - Stock prices in London closed largely lower on Monday, as investors were unable to shake off concerns surrounding the conflict in the Middle East, while developments in the US bond market added to the drama.

Read more
23 Oct 2023 08:45

TOP NEWS: AstraZeneca says Enhertu approved by European Commission

(Alliance News) - AstraZeneca PLC on Monday said its Enhertu treatment has been approved by the European Commission to treat adult lung cancer patients.

Read more
23 Oct 2023 07:46

LONDON BRIEFING: Keller expects higher profit; Upland rejects approach

(Alliance News) - Stocks in London are set to open slightly higher on Monday, as risk sentiment improves after a difficult period for markets last week.

Read more
18 Oct 2023 09:04

AstraZeneca drug Solaris approved in China as NMOSD treatment

(Alliance News) - AstraZeneca PLC on Wednesday announced that eculizumab, whose brand name is Solaris, has been approved in China to treat patients with neuromyelitis optica spectrum disorder

Read more
17 Oct 2023 12:06

LONDON MARKET MIDDAY: European markets uneasy but FTSE 100 outperforms

(Alliance News) - London's FTSE 100 higher was higher around midday, though it was defensive stocks such as utilities and pharmaceuticals which led the charge, suggesting there is still lingering discomfort in markets amid tensions in the Middle East.

Read more
16 Oct 2023 08:34

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival.

Read more
4 Oct 2023 12:14

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes.

Read more
3 Oct 2023 16:55

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
3 Oct 2023 08:36

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

Read more
3 Oct 2023 07:41

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging.

Read more
3 Oct 2023 07:24

AstraZeneca agrees to settle most Nexium, Prilosec claims

(Sharecast News) - Global pharmaceutical company AstraZeneca has agreed to settle litigation on product liability related to two of its widely-used heartburn drugs, Nexium and Prilosec, it announced on Tuesday.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.